Literature DB >> 8019371

Relationship of serum uric acid to cancer occurrence in a prospective male cohort.

L N Kolonel1, C Yoshizawa, A M Nomura, G N Stemmermann.   

Abstract

Uric acid is a potent antioxidant and thus might protect against cancer. To test this hypothesis, we examined the relationship of serum uric acid to subsequent cancer incidence in a cohort of Japanese men in Hawaii. The study population consisted of 7889 men identified in the years 1965-1968 and followed by active hospital surveillance through November 1991. Cancer risk by serum uric acid level was analyzed using Cox proportional hazards regression with adjustment for age and, where indicated, smoking, alcohol use, and body mass index. No significant associations were seen for total cancer (1544 cases), or for cancers of the stomach (214), colon (272), rectum (105), lung (223), bladder (89), or hematopoietic system (77). For prostate cancer (293 cases), a positive association was found (relative risk for highest versus lowest quartile of serum uric acid = 1.5; 95% confidence interval 1.1-2.1; p for trend = 0.04). When the interval from examination to diagnosis was considered, this association was strongest for cases diagnosed in the first 10 years, was attenuated after 15 years, and disappeared completely after 20 years. The findings from this study do not support the hypothesis that uric acid protects against cancer occurrence.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8019371

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  18 in total

1.  Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett's esophagus, and high-grade dysplasia/esophageal adenocarcinoma.

Authors:  Matthew F Buas; Haiwei Gu; Danijel Djukovic; Jiangjiang Zhu; Lynn Onstad; Brian J Reid; Daniel Raftery; Thomas L Vaughan
Journal:  Metabolomics       Date:  2017-01-20       Impact factor: 4.290

Review 2.  Insight into rheumatological cause and effect through the use of Mendelian randomization.

Authors:  Philip C Robinson; Hyon K Choi; Ron Do; Tony R Merriman
Journal:  Nat Rev Rheumatol       Date:  2016-07-14       Impact factor: 20.543

3.  Predictors of cancer mortality in elderly subjects.

Authors:  A Mazza; E Casiglia; R Scarpa; V Tikhonoff; A Pizziol; E Sica; A C Pessina
Journal:  Eur J Epidemiol       Date:  1999-05       Impact factor: 8.082

4.  Serum Urate, Genetic Variation, and Prostate Cancer Risk: Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Anqi Wang; John R Barber; Adrienne Tin; Angelo M De Marzo; Anna Kottgen; Corinne E Joshu; Elizabeth A Platz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-07       Impact factor: 4.254

5.  Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy: a study of the Turkish Descriptive Oncological Researches Group.

Authors:  Ozgur Tanriverdi; Suna Cokmert; Esin Oktay; Kezban Nur Pilanci; Serkan Menekse; Muharrem Kocar; Cenk Ahmet Sen; Nilufer Avci; Tulay Akman; Cetin Ordu; Gamze Goksel; Nezih Meydan
Journal:  Med Oncol       Date:  2014-09-13       Impact factor: 3.064

6.  Use of penalized splines in extended Cox-type additive hazard regression to flexibly estimate the effect of time-varying serum uric acid on risk of cancer incidence: a prospective, population-based study in 78,850 men.

Authors:  Alexander M Strasak; Stefan Lang; Thomas Kneib; Larry J Brant; Jochen Klenk; Wolfgang Hilbe; Willi Oberaigner; Elfriede Ruttmann; Lalit Kaltenbach; Hans Concin; Günter Diem; Karl P Pfeiffer; Hanno Ulmer
Journal:  Ann Epidemiol       Date:  2008-10-04       Impact factor: 3.797

7.  Serum uric acid and the risk of mortality during 23 years follow-up in the Scottish Heart Health Extended Cohort Study.

Authors:  Stephen P Juraschek; Hugh Tunstall-Pedoe; Mark Woodward
Journal:  Atherosclerosis       Date:  2014-01-30       Impact factor: 5.162

8.  Contribution of uric acid to cancer risk, recurrence, and mortality.

Authors:  Mehdi A Fini; Anthony Elias; Richard J Johnson; Richard M Wright
Journal:  Clin Transl Med       Date:  2012-08-15

9.  Serum uric Acid levels in oral cancer patients seen at tertiary institution in Nigeria.

Authors:  A O Lawal; B Kolude; B F Adeyemi
Journal:  Ann Ib Postgrad Med       Date:  2012-06

Review 10.  Serum Uric Acid Increases Risk of Cancer Incidence and Mortality: A Systematic Review and Meta-Analysis.

Authors:  Shushan Yan; Pengjun Zhang; Wei Xu; Yuqing Liu; Bin Wang; Tao Jiang; Changjiang Hua; Xuan Wang; Donghua Xu; Beicheng Sun
Journal:  Mediators Inflamm       Date:  2015-10-04       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.